Why is Piramal Pharma falling/rising?

As of 21-Jul, Piramal Pharma Ltd's stock price is currently at 211.70, reflecting a rise of 0.5 (0.24%). The stock has shown strong performance recently, outperforming its sector by 0.56% today. Over the past week, it has increased by 1.85%, and in the last month, it has risen by 8.20%. Despite a year-to-date decline of 20.35%, the stock has generated a notable return of 43.09% over the past year, significantly outperforming the broader market's return of 1.98%. The company has demonstrated healthy long-term growth, with operating profit growing at an annual rate of 286.94%. However, it faces challenges such as a high Debt to EBITDA ratio of 3.21 times, indicating a low ability to service debt, which could weigh on investor sentiment.
In the broader market context, while Piramal Pharma's recent returns have been positive, the benchmark index, Sensex, has shown a slight decline of 0.06% over the past week. This contrast highlights the stock's resilience in a generally weak market environment. Additionally, the stock's liquidity remains adequate for trading, although there has been a significant drop in delivery volume, which fell by 59.79% against the 5-day average. The high institutional holdings at 46.27% suggest that informed investors are backing the stock, despite its expensive valuation and low profitability metrics. Overall, the stock's recent upward movement can be attributed to its strong performance metrics and institutional support, even as it navigates challenges related to debt and profitability.